Analysis of MHC-restricted tumor rejection antigen induced by IL-12.
Analysis of MHC-restricted tumor rejection antigen induced by IL-12.
批准号:
11671973
负责人:
UMEZU Yasuiki
金额:
$2.56万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Genetic effects of human-tumor cells derived peptides were investigated. Because IL-12 gene transfected tumor cells highly expressed MHC class I molecules, IL-12 gene was transfected into human tumor derived cells. However, those transfected tumor cells did not grow well. This growth inhibitory activity depends on p35 gene which was a half part of IL-12 gene. So, parental tumor cells were used in the following experiments. Mass-culture of human tumor cells was done. After cell surface peptides were collected by pH3.4 citrate-phosphate buffer solution, crude samples were filtered by specific membrane systems. Low molecular peptides (M.W.1000〜6,500 Dalton) were extracted by HPLC system. One peak among multiple peaks obtained was added to normal human cells. After incubation for several hours, m-RNAs were extracted to examine what and how many genes were up- or down-regulated in eight thousand gene tested. The expression of about two hundred genes was significantly up- or down-regulated. The up-regulated genes were associated with tumor progression, in the other hand ; the down-regulated genes were associated with repression genes against anti-tumorigenic genes. As a result, the character of this peptide was consistent with the growth activity of malignant tumor cells. The investigation hereafter will be focused on the peptides sequences by mass spectrometer. It will be also necessary for analysis of the relations of these huge gene expressions to develop the new methods for multi-dimensional unification.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of tumor immunotherapy by vaccinated cancer cells
-
批准号:05671655
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1993
-
负责人:UMEZU Yasuiki
-
依托单位:
国内基金
海外基金
基于PAR1介导的MHC class I表达探讨血府逐瘀汤逆转肺癌免疫逃逸的作用及机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:李燕
-
依托单位: